Your browser doesn't support javascript.
loading
Is the Oncological Outcome of Early Stage Uterine Carcinosarcoma Different from That of Grade 3 Endometrioid Adenocarcinoma?
Güngördük, Kemal; Plett, Helmut; Gülseren, Varol; Meydanli, Mutlu; Boyraz, Gökhan; Özdemir, IsaAykut; Sahin, Hanifi; Senol, Taylan; Yildirim, Nuri; Turan, Taner; Öge, Tufan; Gökçü, Mehmet; Taskin, Salih; Ayhan, Ali; Ataseven, Beyhan.
Afiliación
  • Güngördük K; Department of Gynecologic Oncology, Mugla Sitki Kocman University Education and Research Hospital, Izmir, Turkey.
  • Plett H; Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany.
  • Gülseren V; Department of Gynecology, Charité University Hospital, Berlin, Germany.
  • Meydanli M; Department of Gynecologic Oncology, Tepecik Education and Research Hospital, Faculty of Medicine, University of Health Sciences, Izmir, Turkey, varol_erc@hotmail.com.
  • Boyraz G; Department of Gynecologic Oncology, Zekai Tahir Burak Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey.
  • Özdemir I; Department of Gynecologic Oncology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey.
  • Sahin H; Department of Gynecologic Oncology, Dr. Sadi Konuk Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Istanbul, Turkey.
  • Senol T; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Ankara, Turkey.
  • Yildirim N; Department of Gynecologic Oncology, Zenyep Kamil Women's Health Education and Research Hospital, Faculty of Medicine, University of Health Sciences, Istanbul, Turkey.
  • Turan T; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, School of Medicine, Ege University, Izmir, Turkey.
  • Öge T; Department of Gynecologic Oncology, Etlik Zubeyde Hanim Women's Health Training and Research Hospital, Faculty of Medicine, University of Health Sciences, Ankara, Turkey.
  • Gökçü M; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, School of Medicine, Eskisehir Osman Gazi University, Eskisehir, Turkey.
  • Taskin S; Department of Gynecologic Oncology, Tepecik Education and Research Hospital, Faculty of Medicine, University of Health Sciences, Izmir, Turkey.
  • Ayhan A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, School of Medicine, Ankara University, Ankara, Turkey.
  • Ataseven B; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Baskent University, Ankara, Turkey.
Oncol Res Treat ; 44(1-2): 43-51, 2021.
Article en En | MEDLINE | ID: mdl-33249415
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinosarcoma / Neoplasias Endometriales / Carcinoma Endometrioide Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans País/Región como asunto: Asia / Europa Idioma: En Revista: Oncol Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinosarcoma / Neoplasias Endometriales / Carcinoma Endometrioide Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans País/Región como asunto: Asia / Europa Idioma: En Revista: Oncol Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Suiza